Open AccessTherapeutic efficacy of atezolizumab plus bevacizumab for hepatocellular carcinoma with WNT/β‑catenin signal activation
Author(s) -
Akifumi Kuwano,
Masayoshi Yada,
Fumiya Narutomi,
Shigehiro Nagasawa,
Masatake Tanaka,
Kazuki Kurosaka,
Yoshihiro Ohishi,
Akihide Masumoto,
Kenta Motomura
Publication year - 2022
Publication title -
oncology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 54
eISSN - 1792-1082
pISSN - 1792-1074
DOI - 10.3892/ol.2022.13337
Subject(s) - atezolizumab , wnt signaling pathway , medicine , bevacizumab , cancer research , catenin , oncology , cancer , signal transduction , biology , immunotherapy , chemotherapy , microbiology and biotechnology , pembrolizumab
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom